Abstract
Adriamycin, a lipid-interacting anti-cancer agent, was found to inhibit phospholipid-sensitive Ca2+-dependent phosphorylation of endogenous proteins from the cytosol of the guinea-pig heart. The drug, unexpectedly, also inhibited phosphorylation of separate endogenous proteins in the cardiac cytosol and membranes catalysed by the calmodulin-sensitive species of Ca2+-dependent protein kinase. In both phosphorylation systems, the inhibition by adriamycin was reversed by either phospholipid (phosphatidylserine or cardiolipin) or calmodulin respectively. Adriamycin also inhibited phosphorylation of histone (exogenous protein) catalysed by purified cardiac phospholipid-sensitive Ca2+-dependent protein kinase, but not that by cyclic AMP-dependent and cyclic GMP-dependent protein kinases. It appears that Ca2+-dependent protein phosphorylation systems, regulated either by phospholipid or calmodulin, may represent hitherto unrecognized sites of action of adriamycin. It remains to be seen whether inhibition by adriamycin of these systems is related to the severe cardiotoxicity, the major adverse effect of the drug that limits its clinical usefulness.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CALENDI E., DIMARCO A., REGGIANI M., SCARPINATO B., VALENTINI L. ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS. Biochim Biophys Acta. 1965 May 11;103:25–49. doi: 10.1016/0005-2787(65)90539-3. [DOI] [PubMed] [Google Scholar]
- Charbonneau H., Cormier M. J. Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatography. Biochem Biophys Res Commun. 1979 Oct 12;90(3):1039–1047. doi: 10.1016/0006-291x(79)91931-4. [DOI] [PubMed] [Google Scholar]
- Chatelain P., Berliner C., Ruysschaert J. M., Jaffé J. Effect of a diazafluoranthen derivative on phospholipases. A study at the air-water interface. Biochim Biophys Acta. 1976 Feb 6;419(3):540–546. doi: 10.1016/0005-2736(76)90264-9. [DOI] [PubMed] [Google Scholar]
- Di Marco A., Gaetani M., Scarpinato B. Adriamycin (NSC-123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969 Feb;53(1):33–37. [PubMed] [Google Scholar]
- Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J. M. Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim Biophys Acta. 1980 Mar 27;597(1):1–14. doi: 10.1016/0005-2736(80)90145-5. [DOI] [PubMed] [Google Scholar]
- Kuo J. F., Andersson R. G., Wise B. C., Mackerlova L., Salomonsson I., Brackett N. L., Katoh N., Shoji M., Wrenn R. W. Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7039–7043. doi: 10.1073/pnas.77.12.7039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuo W. N., Kuo J. F. Isolation of stimulatory modulator of guanosine 3':5'-monophosphate-dependent protein kinase from mammalian heart devoid of inhibitory modulator of adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem. 1976 Jul 25;251(14):4283–4286. [PubMed] [Google Scholar]
- Mori T., Takai Y., Minakuchi R., Yu B., Nishizuka Y. Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J Biol Chem. 1980 Sep 25;255(18):8378–8380. [PubMed] [Google Scholar]
- Oldham R. K., Pomeroy T. C. Treatment of Ewing's sarcoma with adriamycin (NSC-123127). Cancer Chemother Rep. 1972 Oct;56(5):635–639. [PubMed] [Google Scholar]
- Pigram W. J., Fuller W., Hamilton L. D. Stereochemistry of intercalation: interaction of daunomycin with DNA. Nat New Biol. 1972 Jan 5;235(53):17–19. doi: 10.1038/newbio235017a0. [DOI] [PubMed] [Google Scholar]
- Schatzman R. C., Wise B. C., Kuo J. F. Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs. Biochem Biophys Res Commun. 1981 Feb 12;98(3):669–676. doi: 10.1016/0006-291x(81)91166-9. [DOI] [PubMed] [Google Scholar]
- Shoji M., Patrick J. G., Davis C. W., Kuo J. F. Guanosine cyclic monophosphate-dependent protein kinase from foetal calf heart. Purification, general properties and catalytic subunit. Biochem J. 1977 Feb 1;161(2):213–221. doi: 10.1042/bj1610213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simon G., Rouser G. Species variations in phospholipid class distribution of organs. II. Heart and skeletal muscle. Lipids. 1969 Nov;4(6):607–614. doi: 10.1007/BF02531048. [DOI] [PubMed] [Google Scholar]
- Takai Y., Kishimoto A., Iwasa Y., Kawahara Y., Mori T., Nishizuka Y. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem. 1979 May 25;254(10):3692–3695. [PubMed] [Google Scholar]
- Tanaka T., Hidaka H. Hydrophobic regions function in calmodulin-enzyme(s) interactions. J Biol Chem. 1980 Dec 10;255(23):11078–11080. [PubMed] [Google Scholar]
- Tritton T. R., Murphree S. A., Sartorelli A. C. Adriamycin: a proposal on the specificity of drug action. Biochem Biophys Res Commun. 1978 Oct 16;84(3):802–808. doi: 10.1016/0006-291x(78)90775-1. [DOI] [PubMed] [Google Scholar]
- Weiss B., Levin R. M. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. Adv Cyclic Nucleotide Res. 1978;9:285–303. [PubMed] [Google Scholar]
- Wrenn R. W., Katoh N., Wise B. C., Kuo J. F. Stimulation by phosphatidylserine and calmodulin of calcium-dependent phosphorylation of endogenous proteins from cerebral cortex. J Biol Chem. 1980 Dec 25;255(24):12042–12046. [PubMed] [Google Scholar]